• Author: Jordana B. Cohen
Clear all

First-line β-blocker use for hypertension in the Veterans Health Administration

Abstract: Importance: Starting in 2014, US guidelines have not recommended β-blockers for first-line treatment of hypertension in the absence of compelling indications due to …

A clinical trial evaluating pharmacist-guided self-management of hypertension among Veterans with CKD, rationale and study design

Abstract: RATIONALE & OBJECTIVE: Chronic kidney disease (CKD) associates with high morbidity and mortality due to CKD progression and cardiovascular disease (CVD). Blood pressure …

Antihypertensive medication co-pay and adherence among Veterans receiving care within the Veterans Health Administration

Abstract: Background: Despite safe, effective, and relatively affordable antihypertensive therapies, blood pressure (BP) control remains suboptimal. One potential contributor is …

Trends in initial antihypertensive medication prescribing among >2.8 million Veterans newly diagnosed with hypertension, 2000 to 2019

Abstract: Background: Among patients diagnosed with high blood pressure (BP), initial dual therapy has been recommended for patients with high pretreatment systolic BP …

Development of a risk-prediction model for primary aldosteronism in veterans with hypertension

Abstract: Background: Rates of screening for primary aldosteronism in patients who meet the criteria are exceedingly low (1%-3%). To help clinicians prioritize screening in …